# Shire Pharmaceutical Contracts (Shire Pharmaceutical Contracts Limited)

Private limited company registered in London, classed under “Other service activities n.e.c.”.

- Company number: 02024595
- Status: Active
- Type: Private limited company
- Incorporated: 2 June 1986
- Registered office: 1 Kingdom Street, London, W2 6BD
- Location: London
- Activity: Other service activities n.e.c.

## Latest filed profit

No profit figure in its latest filed accounts.

Turnover, net assets, cash, staff, earlier years, ratios and owners are on the page for subscribers.

## Questions people ask

### What does Shire Pharmaceutical Contracts do?

Private limited company registered in London, classed under “Other service activities n.e.c.”.

### How much turnover does Shire Pharmaceutical Contracts make?

Answered on the page for FirmFacts Pro subscribers: https://firmfacts.co/company/shire-pharmaceutical-contracts-02024595

### Is Shire Pharmaceutical Contracts profitable?

Shire Pharmaceutical Contracts's profit isn't public: small companies may file without a profit and loss account.

### Who runs and owns Shire Pharmaceutical Contracts?

Its directors are Seyda Atadan Memis, Marc Stuart Page. Its owners are shown to subscribers.

### Where is Shire Pharmaceutical Contracts based?

Its registered office is 1 Kingdom Street, London, W2 6BD, in London.

### When was Shire Pharmaceutical Contracts founded?

Shire Pharmaceutical Contracts Limited was incorporated on 2 June 1986.

### Is Shire Pharmaceutical Contracts still trading?

The register lists Shire Pharmaceutical Contracts Limited as active.

## Timeline

Recent filings and changes at Companies House.

- 2026-09-25: Director's details changed for Ms Seyda Atadan Memis on 10 August 2026
- 2025-11-26: Full accounts made up to 31 March 2025
- 2025-09-10: Termination of appointment of Peter Michael Grubin as a director on 2 September 2025
- 2025-07-10: Director's details changed for Mr Peter Michael Grubin on 29 May 2025
- 2024-12-18: Full accounts made up to 31 March 2024
- 2024-12-02: Register(s) moved to registered inspection location (and 1 more like it since 17 January 2017)
- 2024-11-29: Register inspection address has been changed (and 1 more like it since 13 January 2017)
- 2024-02-19: Director's details changed for Ms Seyda Atadan Memis on 1 September 2023
- 2023-12-19: Full accounts made up to 31 March 2023
- 2023-06-13: Full accounts made up to 31 March 2022
- 2023-06-02: Termination of appointment of Takeda Corporate Services Limited as a secretary on 31 May 2023
- 2023-03-10: Notification of Takeda Uk Limited as a person with significant control on 21 December 2022
- 2023-03-10: Cessation of Shire Pharmaceuticals Group as a person with significant control on 21 December 2022
- 2023-01-26: Termination of appointment of Jonathan Clark Neal as a director on 18 January 2023
- 2022-11-10: Termination of appointment of Mark Gibbons as a director on 8 November 2022
- 2022-08-23: Appointment of Ms Seyda Atadan Memis as a director on 1 August 2022
- 2022-05-19: Full accounts made up to 31 March 2021
- 2022-03-21: Appointment of Peter Michael Grubin as a director on 1 March 2022
- 2022-03-21: Termination of appointment of Kentaro Shirahata as a director on 1 March 2022
- 2021-11-11: Statement of capital on 11 November 2021 · GBP 1
- 2021-11-11: Solvency Statement dated 09/11/21
- 2021-11-11: Statement by Directors
- 2021-11-11: Resolutions (and 1 more like it since 19 May 2010)
- 2021-04-13: Full accounts made up to 31 March 2020
- 2020-12-01: Appointment of Mr Kentaro Shirahata as a director on 30 November 2020

---

Source: Companies House filings (Open Government Licence v3.0). Figures are as filed; nothing is estimated. Page: https://firmfacts.co/company/shire-pharmaceutical-contracts-02024595